Why these 4 ASX shares have rocketed higher today

The iSentia Group Ltd (ASX:ISD) share price has been one of four climbing higher today. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another disappointing day for the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO). In early afternoon trade the benchmark index is down 1% to 5,892 points.

Despite the market falling lower, four shares in particular have managed to put on strong gains today. Here's why they've rocketed higher:

The Emerchants Ltd (ASX: EML) share price is up 5% to $1.53 after releasing a positive shareholder update. The update revealed that the payment solutions company's strong performance has continued in the third quarter. Furthermore, the company believes it has positioned itself to be able to accelerate revenue and earnings growth next year.

The iSentia Group Ltd (ASX: ISD) share price has jumped almost 8% to $1.57 after releasing its Macquarie Australia Conference presentation. The lack of further bad news regarding its embattled content marketing business appears to be the reason behind the media monitoring company's gain today. Whilst this is definitely a positive, I would hold off an investment until its full-year results have been announced later this year.

The Melbourne IT Limited (ASX: MLB) share price has jumped 10% to $2.36 following a successful institutional entitlement offer to raise $19 million at $2.10 per share. The funds will be used to acquire WME Group, a leading provider of end-to-end digital marketing solutions. The deal is expected to be earnings accretive by between 12% and 18% in FY 2017. Melbourne IT could be worth a closer look

The Zelda Therapeutics Ltd (ASX: ZLD) share price has bounced back from yesterday's heavy decline with a 6% gain to 9 cents. Although I think this pot stock could potentially have a bright future, I think investors would be better off waiting for the results of its clinical trials later this year.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »